Walter Kraft, MD

Professor
Director, Division of Clinical Pharmacology
Director, Clinical Research Unit
Director, Office of Human Research

Walter Kraft

Contact

132 South 10th Street
1170 Main Building
Philadelphia, PA 19107

Email Walter K. Kraft

215-955-9077
215-955-5681 fax

Featured Links

Walter Kraft, MD

Professor
Director, Division of Clinical Pharmacology
Director, Clinical Research Unit
Director, Office of Human Research

Education

Medical School

University of Pittsburgh

Residency

Thomas Jefferson University Hospital

Fellowship

Thomas Jefferson University Hospital

Publications

Scopus Feed has no publications.

Board Certification

Internal Medicine
Clinical Pharmacology

Hospital Appointment

Thomas Jefferson University Hospital

Research Interests

  • Phase one clinical trials
  • Treatment of neonatal abstinence syndrome
  • Clinical Pharmacology

Clinical Interests

  • Anticoagulation
  • Hospital-based vascular medicine consultation

Industrial Relevance

Dr. Kraft has expertise in the clinical, regulatory, and managerial aspects of Phase 1 drug development.

Biography

Dr. Kraft is an internist and a clinical pharmacologist. He is the director of the Thomas Jefferson University Clinical Research Unit. The CRU, located within the Thomas Jefferson University Hospital, specializes in Phase 1 trials in federally funded and industry sponsored investigations. Populations have included both heathy volunteers, as well as adult and pediatric patients with cancer, Hepatitis C, end stage renal disease, epilepsy, hemophilia, and migraine. He has an interest in the development of novel therapeutics in the neonatal abstinence syndrome (NAS). He is co-PI on the NIGMS funded fellowship program in Clinical Pharmacology at Jefferson. He is director of the Jefferson Office of Human Research, which oversees all human subjects’ protection for the Jefferson enterprise.  He had held national leadership in a number of professional organizations including treasurer of American Society for Clinical Pharmacology and Therapeutics, and board membership on American Board of Clinical Pharmacology. He currently serves on the FDA advisory committee for Clinical Pharmacology. Lastly, he maintains a clinical practice in vascular medicine and the treatment of complex venous and arterial thrombotic diseases.